NEUWAY PHARMA
NEUWAY Pharma is committed to bringing transformative neuropharmaceuticals across the blood-brain barrier through its EnPC®, the drug delivery technology based on a natural derived protein capsule. In addition to advancing its proprietary pipeline, the company aims to be a partner of choice in particular for antibody and mRNA drug developers stymied by the hurdles of delivering these and other drug modalities into the brain and CNS tissue. Operating as a drug developer and a delivery expert, NEUWAY will demonstrate the value of its technology through its internal orphan neurological disease pipeline and partnered programs.
NEUWAY PHARMA
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2014-04-01
Address:
Bonn, Nordrhein-Westfalen, Germany
Country:
Germany
Website Url:
http://www.neuway-pharma.com
Total Employee:
11+
Status:
Active
Contact:
49 228 522 798 0
Total Funding:
5.85 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Apache Microsoft Exchange Online
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Aprea
Aprea is a biopharmaceutical company that develops novel cancer therapeutics.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
LYSOGENE
Lysogene is a pioneer in the basic research and clinical development of gene therapy for neurodegenerative disorders.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
Current Advisors List
Current Employees Featured
Founder
Investors List
KfW
KfW investment in Series A - NEUWAY Pharma
Wellington Partners
Wellington Partners investment in Series A - NEUWAY Pharma
Wellington Partners
Wellington Partners investment in Series A - NEUWAY Pharma
Official Site Inspections
http://www.neuway-pharma.com Semrush global rank: 4.89 M Semrush visits lastest month: 1.79 K
- Host name: alfa3046.alfahosting-server.de
- IP address: 109.237.140.8
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "NEUWAY Pharma"
NEUWAY Pharma GmbH
NEUWAY PHARMA GmbH is a preclinical biotech company based in Bonn, Germany. The company is focusing on the development of innovative therapeutics for treatment of brain …See details»
NEUWAY Pharma - Crunchbase Company Profile
NEUWAY Pharma is committed to bringing transformative neuropharmaceuticals across the blood-brain barrier through its EnPC®, the drug delivery technology …See details»
NEUWAY Pharma – Qualified for CNS Drug Delivery
Aug 16, 2016 · NEUWAY Pharma GmbH, Bonn, Germany is focusing on the preclinical and clinical development of innovative therapeutics for treatment of brain diseases based on its …See details»
Management - Neuway Pharma
ADDRESS NEUWAY Pharma GmbH In den Dauen 6A 53117 Bonn, Germany. CONTACT Phone +49 (0)228 522798-0 Fax +49 (0)228 522798-99. CAREER Applications from highly skilled professionals are always welcomeSee details»
NEUWAY Pharma GmbH Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for NEUWAY Pharma GmbH of Bonn, Nordrhein-Westfalen. Get the latest business insights from Dun & …See details»
NEUWAY Pharma (NEUWAY Pharma GmbH) - Startbase
Development of preclinical and clinical innovative therapeutics for the treatment of severe rare brain diseases based on a proprietary CNS drug delivery platform.See details»
NEUWAY Pharma GmbH - Bonn, Germany - bionity.com
NEUWAY Pharma GmbH, Bonn, Germany, is focusing on the preclinical and clinical development of innovative therapeutics for treatment of severe orphan brain diseases based on its …See details»
Neuway Pharma GmbH | EURAS
Over the years NEUWAY has developed a broad expertise in the production of the capsules including CMC as well as their drug loading. Internally, NEUWAY has focused primarily on the …See details»
NEUWAY Pharma - News, Articles etc. - European Pharmaceutical …
News stories and articles referencing NEUWAY Pharma on European Pharmaceutical Review Recommended New webinar with Fujifilm: Monocyte activation test (MAT): Insight into …See details»
Discovering Stealth Companies: Neuway Pharma from …
Jun 16, 2021 · Neuway Pharma GmbH (Neuway) is a German preclinical biotech company with an interest in gene therapy. They’re focused on innovative therapeutics for the treatment of CNS-related genetic diseases based on …See details»
NEUWAY Pharma | VentureRadar
NEUWAY focuses on the pre-clinical development of innovative therapeutics for treatment of severe diseases with high medical need based on its proprietary Drug Delivery Platform so …See details»
NEUWAY Pharma and WACKER Launch Research Project to …
Oct 12, 2022 · Bonn-based biotech company NEUWAY Pharma and Munich-based chemical company WACKER have launched a research project to identify and manufacture RNA-based …See details»
NEUWAY Pharma (NEUWAY Pharma GmbH) - Startbase
Entwicklung von präklinischen und klinischen, innovativen Therapeutika zur Behandlung schwerer seltener Hirnerkrankungen, basierend auf einer proprietären CNS Drug Delivery Platform.See details»
Partnering - Neuway Pharma
NEUWAY’s internal pipeline project may be partnered by co-development or complete asset transfer at different preclinical stages. NEUWAY intends to combine partnered programs with …See details»
Neuway Pharma taps $3.3M in funding to develop drugs to treat …
Jun 14, 2016 · German biotech startup Neuway Pharma has tapped into $3.3 million (€2.95 million) of funding from the country’s Federal Ministry of Education and Research that the …See details»
NEUWAY Pharma Appoints Dr Oliver Ernst as Chief Executive …
Sep 20, 2022 · BONN, Germany-- ( BUSINESS WIRE )-- NEUWAY Pharma GmbH, « NEUWAY », a highly innovative biotechnology company specializing in the delivery of mRNA and other …See details»
Neuway Pharma GmbH - DevelopmentAid
Neuway Pharma GmbH — Consulting Organization from Germany, has experience with Horizon 2020 (2014 - 2020), Horizon Europe (2021 - 2027), it`s involved in Health, Research sectorsSee details»
NEUWAY Pharma Announces Formation of Scientific Advisory Board
Jul 6, 2021 · NEUWAY’s SAB will provide scientific guidance and advice as the Company defines its preclinical and early clinical strategies for its proprietary EnPC platform.See details»
Crossing the barrier to treating brain diseases - Nature
Building on an evolutionary ruse to cross the physiological blood–brain barrier, NEUWAY Pharma’s engineered protein capsules (EnPC) are poised to usher in a new era of effective …See details»
Pipeline - Neuway Pharma
NEUWAY has established an in-house pipeline targeting severe orphan CNS diseases with very high medical need. The therapeutics will be delivered with NEUWAY’s proprietary delivery …See details»